Synonyms: MK7762 | TBD09
Compound class:
Synthetic organic
Comment: MK-7762 (also known as TBD09) is the oxazolidinone antibacterial compound claimed in Merck's patent WO2021188606A1 [1]. It is being developed as a treatment for tuberculosis (TB) by Merck and the Bill & Melinda Gates Medical Research Institute.
|
|
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel